MedHeron helps your team prepare its FDA submission. Our AI agents research regulatory pathways, compare potential predicates, draft source-linked comparisons, and flag pre-flight gaps—so you know what’s needed and what to do next.
The submission landscape
We studied FDA records to understand the challenges facing first-time teams.
+54 days
Median receipt-to-decision time
44%
Among applicants with one recorded submission
175,607
The historical dataset behind this research
Public data. Real context.
Historical calendar timelines—not FDA review-clock time or promised time savings.
July 2026 openFDA snapshot; decisions since January 2025. Applicants with one record in the dataset (881) had a median of 177 calendar days, versus 123 for repeat applicants (4,156). Names were normalized; company name changes can affect grouping. Elapsed time includes applicant responses, not just FDA review. This is historical context, not a measured benefit of MedHeron. Source: openFDA bulk data
Identify product codes, pathways, and source-backed predicate comparisons.
In preview
Align your team on intended use, testing norms, and Q-Submission questions.
In preview
Track evidence tasks, draft source-linked SE sections, and catch RTA gaps.
In preview
Assemble submission-ready eSTAR sections and respond to FDA review holds.
Coming next
MedHeron searches FDA records using your device description and highlights relevant candidates, so you can compare intended uses and review the source evidence.
From your first questions to a clearer submission plan—see how MedHeron helps your team move forward.
Candidates require regulatory review.